Latest Insider Transactions at Cme Group Inc. (CME)
This section provides a real-time view of insider transactions for Cme Group Inc. (CME). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CME GROUP INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CME GROUP INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 22
2025
|
Daniel G Kaye Director |
SELL
Open market or private sale
|
Direct |
500
-12.0%
|
$141,000
$282.42 P/Share
|
|
May 20
2025
|
Jonathan L Marcus Sr MD General Counsel |
SELL
Open market or private sale
|
Direct |
390
-5.49%
|
$108,030
$277.5 P/Share
|
|
May 19
2025
|
Phyllis M Lockett Director |
SELL
Open market or private sale
|
Direct |
1,060
-25.43%
|
$293,620
$277.88 P/Share
|
|
May 15
2025
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
300
-1.2%
|
$81,900
$273.17 P/Share
|
|
May 15
2025
|
Charles P Carey Director |
SELL
Open market or private sale
|
Indirect |
3,000
-35.71%
|
$816,000
$272.56 P/Share
|
|
May 05
2025
|
Derek Sammann Sr MD Gl Hd Commodities Mkts |
SELL
Open market or private sale
|
Indirect |
4,650
-17.92%
|
$1,302,000
$280.62 P/Share
|
|
Apr 29
2025
|
Dennis Suskind Director |
SELL
Open market or private sale
|
Direct |
1,000
-25.54%
|
$271,000
$271.28 P/Share
|
|
Apr 25
2025
|
Larry G Gerdes Director |
SELL
Open market or private sale
|
Direct |
2,000
-5.17%
|
$532,000
$266.12 P/Share
|
|
Apr 24
2025
|
Larry G Gerdes Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.49%
|
$528,000
$264.1 P/Share
|
|
Mar 26
2025
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
11
+0.45%
|
$2,882
$262.62 P/Share
|
|
Mar 26
2025
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
262
+0.1%
|
$68,644
$262.62 P/Share
|
|
Mar 18
2025
|
Derek Sammann Sr MD Gl Hd Commodities Mkts |
BUY
Other acquisition or disposition
|
Indirect |
2,175
+11.47%
|
-
|
|
Mar 18
2025
|
Derek Sammann Sr MD Gl Hd Commodities Mkts |
SELL
Other acquisition or disposition
|
Direct |
2,175
-18.76%
|
-
|
|
Mar 15
2025
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.38%
|
$23,478
$258.68 P/Share
|
|
Mar 15
2025
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
308
+1.28%
|
$79,464
$258.68 P/Share
|
|
Mar 15
2025
|
Lynne Fitzpatrick President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
722
-1.34%
|
$186,276
$258.68 P/Share
|
|
Mar 15
2025
|
Lynne Fitzpatrick President and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,451
+3.85%
|
$374,358
$258.68 P/Share
|
|
Mar 15
2025
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,625
-6.36%
|
$419,250
$258.68 P/Share
|
|
Mar 15
2025
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,668
+12.55%
|
$946,344
$258.68 P/Share
|
|
Mar 15
2025
|
Jonathan L Marcus Sr MD General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
269
-3.65%
|
$69,402
$258.68 P/Share
|
|
Mar 15
2025
|
Suzanne Sprague COO & Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
722
-2.66%
|
$186,276
$258.68 P/Share
|
|
Mar 15
2025
|
Suzanne Sprague COO & Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct |
1,453
+7.28%
|
$374,874
$258.68 P/Share
|
|
Mar 15
2025
|
Derek Sammann Sr MD Gl Hd Commodities Mkts |
SELL
Payment of exercise price or tax liability
|
Direct |
1,708
-10.9%
|
$440,664
$258.68 P/Share
|
|
Mar 15
2025
|
Derek Sammann Sr MD Gl Hd Commodities Mkts |
BUY
Grant, award, or other acquisition
|
Direct |
3,883
+19.85%
|
$1,001,814
$258.68 P/Share
|
|
Mar 15
2025
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,436
-4.71%
|
$370,488
$258.68 P/Share
|
|
Mar 15
2025
|
Hilda Harris Piell Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,451
+10.17%
|
$890,358
$258.68 P/Share
|
|
Mar 15
2025
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,468
-14.5%
|
$2,958,744
$258.68 P/Share
|
|
Mar 15
2025
|
Terrence A Duffy Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
25,887
+24.66%
|
$6,678,846
$258.68 P/Share
|
|
Mar 15
2025
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,816
-5.83%
|
$468,528
$258.68 P/Share
|
|
Mar 15
2025
|
Sunil Cutinho Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,099
+11.63%
|
$1,057,542
$258.68 P/Share
|
|
Mar 15
2025
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
837
-3.37%
|
$215,946
$258.68 P/Share
|
|
Mar 15
2025
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
BUY
Grant, award, or other acquisition
|
Direct |
1,451
+7.85%
|
$374,358
$258.68 P/Share
|
|
Mar 15
2025
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,625
-7.97%
|
$419,250
$258.68 P/Share
|
|
Mar 15
2025
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,668
+15.25%
|
$946,344
$258.68 P/Share
|
|
Mar 14
2025
|
Deborah J Lucas Director |
SELL
Open market or private sale
|
Direct |
1,500
-30.89%
|
$384,000
$256.95 P/Share
|
|
Mar 13
2025
|
Howard J Siegel Director |
SELL
Open market or private sale
|
Indirect |
10,000
-31.37%
|
$2,600,000
$260.0 P/Share
|
|
Mar 11
2025
|
Terrence A Duffy Chairman and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-36.06%
|
$7,770,000
$259.18 P/Share
|
|
Mar 03
2025
|
Suzanne Sprague COO & Global Head of Clearing |
SELL
Open market or private sale
|
Direct |
1,500
-15.73%
|
$384,000
$256.83 P/Share
|
|
Feb 27
2025
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
3,984
-12.84%
|
$996,000
$250.47 P/Share
|
|
Feb 27
2025
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
43
-0.18%
|
-
|
|
Feb 13
2025
|
Ken Vroman Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
5,066
-23.26%
|
$1,266,500
$250.0 P/Share
|
|
Feb 13
2025
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
11,592
-34.63%
|
$2,886,408
$249.17 P/Share
|
|
Jan 16
2025
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
60
+2.41%
|
$13,620
$227.96 P/Share
|
|
Jan 16
2025
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
1,368
+0.53%
|
$310,536
$227.96 P/Share
|
|
Dec 31
2024
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,706
-12.33%
|
$2,715,792
$232.23 P/Share
|
|
Dec 27
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
264
+0.1%
|
$61,248
$232.89 P/Share
|
|
Dec 27
2024
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
11
+0.46%
|
$2,552
$232.89 P/Share
|
|
Nov 12
2024
|
Elizabeth A Cook Director |
SELL
Open market or private sale
|
Indirect |
750
-3.95%
|
$169,500
$226.33 P/Share
|
|
Nov 04
2024
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
400
-1.57%
|
$88,800
$222.92 P/Share
|
|
Oct 30
2024
|
Sunil Cutinho Chief Information Officer |
SELL
Open market or private sale
|
Direct |
4,500
-14.26%
|
$1,017,000
$226.64 P/Share
|